CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Glutathione

谷胱甘肽 杂质对照品Glutathione Impurities

EP30 个杂质条目30 impurity entries

本页汇总 谷胱甘肽 的 30 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 30 impurity reference standards of Glutathione with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 谷胱甘肽(Glutathione)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesGlutathione affinity chromatography for the scalable purification of an oncolytic virus immunotherapy from microcarrier cell culture
    Frontiers in bioengineering and biotechnology · 2023 · Swartz AR et al.  ·  PMID 37397964  ·  DOI
  2. 杂质研究Impurity studiesGenotoxic stress-triggered β-catenin/JDP2/PRMT5 complex facilitates reestablishing glutathione homeostasis
    Nature communications · 2019 · Cao L et al.  ·  PMID 31434880  ·  DOI
  3. 杂质研究Impurity studiesChloroform, carbon tetrachloride and glutathione depletion induce secondary genotoxicity in liver cells via oxidative stress
    Toxicology · 2003 · Beddowes EJ et al.  ·  PMID 12699900  ·  DOI
  4. 分析方法Analytical MethodsQualitative and quantitative analysis of glutathione and related impurities in pharmaceuticals by qNMR
    Journal of pharmaceutical and biomedical analysis · 2024 · Shu Q et al.  ·  PMID 38364345  ·  DOI
  5. 分析方法Analytical MethodsValidation and optimisation of reduced glutathione quantification in erythrocytes by means of a coulometric high-performance liquid chromatography analytical method
    Biomedical chromatography : BMC · 2024 · Lauwers S et al.  ·  PMID 39353732  ·  DOI

谷胱甘肽 —— 原料药与杂质对照品Glutathione — drug substance & impurities

共 31 个条目(含原料药本体)31 items incl. the drug substance
Glutathione structure
EP原料药 APIAPI
谷胱甘肽Glutathione
Glutathione
CAS No.70-18-8
Chemical FormulaC10H17N3O6S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 12 (Glutathione EP Impurity A) structure
EPA
谷胱甘肽杂质12 (谷胱甘肽EP杂质A)Glutathione Impurity 12 (Glutathione EP Impurity A)
Glutathione Impurity 12 (Glutathione EP Impurity A)
CAS No.19246-18-5
Chemical FormulaC5H10N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 2 (Glutathione EP Impurity C) structure
EPC
谷胱甘肽杂质2 (谷胱甘肽EP杂质C)Glutathione Impurity 2 (Glutathione EP Impurity C)
Glutathione Impurity 2 (Glutathione EP Impurity C)
CAS No.27025-41-8
Chemical FormulaC20H32N6O12S2
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 11 Trifluoroacetate (Glutathione EP Impurity D Trifluoroacetate) structure
EPD
谷胱甘肽杂质11 三氟乙酸盐 (谷胱甘肽EP杂质D 三氟乙酸盐)Glutathione Impurity 11 Trifluoroacetate (Glutathione EP Impurity D Trifluoroacetate)
Glutathione Impurity 11 Trifluoroacetate (Glutathione EP Impurity D Trifluoroacetate)
CAS No.283159-88-6
Chemical FormulaC8H14N2O5S·C2HF3O2
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 11 (Glutathione EP Impurity D) structure
EPD
谷胱甘肽杂质11 (谷胱甘肽EP杂质D)Glutathione Impurity 11 (Glutathione EP Impurity D)
Glutathione Impurity 11 (Glutathione EP Impurity D)
CAS No.636-58-8
Chemical FormulaC8H14N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 2-13C4,15N2 (Glutathione EP Impurity C-13C4,15N2) structure
EPC-13C4
谷胱甘肽杂质2-13C4,15N2 (谷胱甘肽EP杂质C-13C4,15N2)Glutathione Impurity 2-13C4,15N2 (Glutathione EP Impurity C-13C4,15N2)
Glutathione Impurity 2-13C4,15N2 (Glutathione EP Impurity C-13C4,15N2)
CAS No.1416898-83-3
Chemical FormulaC1613C4H32N415N2O12S2
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 3 structure
3
谷胱甘肽杂质3Glutathione Impurity 3
Glutathione Impurity 3
CAS No.121-24-4
Chemical FormulaC20H32N6O12S2
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 4 structure
4
谷胱甘肽杂质4Glutathione Impurity 4
Glutathione Impurity 4
CAS No.108457-42-7
Chemical FormulaC10H17N3O6S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 7 structure
7
谷胱甘肽杂质7Glutathione Impurity 7
Glutathione Impurity 7
CAS No.139595-20-3
Chemical FormulaC10H15N3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 9 structure
9
谷胱甘肽杂质9Glutathione Impurity 9
Glutathione Impurity 9
CAS No.98-79-3
Chemical FormulaC5H7NO3
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 10 structure
10
谷胱甘肽杂质10Glutathione Impurity 10
Glutathione Impurity 10
CAS No.3773-07-7
Chemical FormulaC10H17N3O9S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 13 structure
13
谷胱甘肽杂质13Glutathione Impurity 13
Glutathione Impurity 13
CAS No.118421-50-4
Chemical FormulaC12H21N3O6S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 14 Monomer structure
14
谷胱甘肽杂质14 单体Glutathione Impurity 14 Monomer
Glutathione Impurity 14 Monomer
CAS No.70555-25-8
Chemical FormulaC15H25N5O9S2
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 16 structure
16
谷胱甘肽杂质16Glutathione Impurity 16
Glutathione Impurity 16
CAS No.35446-36-7
Chemical FormulaC11H14N2O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 17 structure
17
谷胱甘肽杂质17Glutathione Impurity 17
Glutathione Impurity 17
CAS No.274260-05-8
Chemical FormulaC10H17N3O6S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 18 structure
18
谷胱甘肽杂质18Glutathione Impurity 18
Glutathione Impurity 18
CAS No.26289-39-4
Chemical FormulaC16H19N5O10S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 20 structure
20
谷胱甘肽杂质20Glutathione Impurity 20
Glutathione Impurity 20
CAS No.83851-42-7
Chemical FormulaC28H44N2O8S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 21 structure
21
谷胱甘肽杂质21Glutathione Impurity 21
Glutathione Impurity 21
CAS No.72025-60-6
Chemical FormulaC30H47N3O9S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 22 structure
22
谷胱甘肽杂质22Glutathione Impurity 22
Glutathione Impurity 22
CAS No.57564-91-7
Chemical FormulaC10H16N4O7S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 23 structure
23
谷胱甘肽杂质23Glutathione Impurity 23
Glutathione Impurity 23
CAS No.502635-76-9
Chemical FormulaC24H39N5O8S2
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 24 structure
24
谷胱甘肽杂质24Glutathione Impurity 24
Glutathione Impurity 24
CAS No.13081-14-6
Chemical FormulaC13H22N4O8S2
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 25 structure
25
谷胱甘肽杂质25Glutathione Impurity 25
Glutathione Impurity 25
CAS No.90663-73-3
Chemical FormulaC18H29N5O11S2
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 26 structure
26
谷胱甘肽杂质26Glutathione Impurity 26
Glutathione Impurity 26
CAS No.934336-73-9
Chemical FormulaC11H19N3O6S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 27 structure
27
谷胱甘肽杂质27Glutathione Impurity 27
Glutathione Impurity 27
CAS No.7349-78-2
Chemical FormulaC10H20N2O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 28 (N-Nitroso Glutathione Impurity 9) structure
28
谷胱甘肽杂质28 (N-亚硝基谷胱甘肽杂质9)Glutathione Impurity 28 (N-Nitroso Glutathione Impurity 9)
Glutathione Impurity 28 (N-Nitroso Glutathione Impurity 9)
CAS No.80754-96-7
Chemical FormulaC5H6N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 29 structure
29
谷胱甘肽杂质29Glutathione Impurity 29
Glutathione Impurity 29
CAS No.3054-47-5
Chemical FormulaC12H19N3O7S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 30 structure
30
谷胱甘肽杂质30Glutathione Impurity 30
Glutathione Impurity 30
CAS No.857793-65-8
Chemical FormulaC8H14N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 37 structure
37
谷胱甘肽杂质37Glutathione Impurity 37
Glutathione Impurity 37
CAS No.17297-99-3
Chemical FormulaC10H17N3O8S
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 37 Trisodium Salt structure
37
谷胱甘肽杂质37 三钠盐Glutathione Impurity 37 Trisodium Salt
Glutathione Impurity 37 Trisodium Salt
CAS No.3102111-82-7
Chemical FormulaC10H14N3O8S3-·3Na+
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 40 structure
40
谷胱甘肽杂质40Glutathione Impurity 40
Glutathione Impurity 40
CAS No.89680-18-2
Chemical FormulaC10H20N2O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Glutathione Impurity 9-d5 structure
9-D5
谷胱甘肽杂质9-d5Glutathione Impurity 9-d5
Glutathione Impurity 9-d5
CAS No.1086136-22-2
Chemical FormulaC5H2D5NO3
Purity>95%询价On request
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

谷胱甘肽 —— 研究文献与合成路线Glutathione — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 谷胱甘肽 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Glutathione. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Glutathione‑degrading enzymes in the complex landscape of tumors (Review)
    Zhang T, Yao C, Zhou X, et al. · International journal of oncology · 2024 · 被引 30cited 30
  2. Degradation of glutathione and glutathione conjugates in plants
    Ito T, Ohkama-Ohtsu N · Journal of experimental botany · 2023 · 被引 40cited 40
  3. High-Efficiency Degradation of PET Plastics by Glutathione S-Transferase under Mild Conditions
    Huang X, Li Y, Shu Z, et al. · Environmental science & technology · 2024 · 被引 6cited 6
  4. Multifunctional copper-glutathione clusters with superior <i>p</i>-nitrophenol degradation and horseradish peroxidase-like activity
    Oyebanji M, Yang X, Chen L, et al. · RSC advances · 2025 · 被引 4cited 4
  5. Glutathione-dependent degradation of SMARCA2/4 for targeted lung cancer therapy with improved selectivity
    Ji M, Yu D, Liu X, et al. · European journal of medicinal chemistry · 2024 · 被引 4cited 4
  6. Kojic acid accelerates fungicide degradation in papaya fruit by inducing the expression of tau class glutathione S-transferases
    Wang SY, Herrera-Balandrano DD, Cao JJ, et al. · Journal of hazardous materials · 2025 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR PRODUCTION OF REDUCED GLUTATHIONE
    FUKUMOTO KAZUNARI · 公开号 EP2439312EP2439312 · 2012
  2. PROCESS FOR PRODUCTION OF REDUCED GLUTATHIONE
    FUKUMOTO KAZUNARI · 公开号 WO2010140625WO2010140625 · 2010
  3. GLUTATHIONE PRODUCTION PROMOTER AND SKIN CARE PREPARATION AND COSMETIC USING THE GLUTATHIONE PRODUCTION PROMOTOR
    MORIYAMA MASAHIRO, MAEDA TAKAHIRO, TAIRA MASAHIRO · 公开号 JP2010195744JP2010195744 · 2010
  4. GLUTATHIONE PRODUCTION PROMOTER AND SKIN CARE PREPARATION AND COSMETIC USING THE GLUTATHIONE PRODUCTION PROMOTOR
    MORIYAMA MASAHIRO, MAEDA TAKAHIRO, TAIRA MASAHIRO · 公开号 JP2010195743JP2010195743 · 2010
  5. GLUTATHIONE PRODUCTION PROMOTER AND SKIN CARE PREPARATION AND COSMETIC USING THE GLUTATHIONE PRODUCTION PROMOTOR
    MORIYAMA MASAHIRO, MAEDA TAKAHIRO, TAIRA MASAHIRO · 公开号 JP2010195747JP2010195747 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

谷胱甘肽 杂质谱研究要点Glutathione — impurity profiling notes

下面这些是拿到 谷胱甘肽 的 31 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 31 impurity entries for Glutathione, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances